Asia Pacific Immunodiagnostics Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Asia Pacific Immunodiagnostics Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Asia Pacific Immunodiagnostics Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Increasing Use of Point-of-Care Immunodiagnostics

5.2 Market Opportunities

5.2.1 Rising Focus On R&D Investment and Expansion by Key Players

5.3 Future Trends

5.3.1 Technological Advancements in The Field of Immunodiagnostics

5.4 Impact of Drivers and Restraints

6. Asia Pacific Immunodiagnostics Market Regional Analysis

6.1 Asia Pacific Immunodiagnostics Market Overview

6.2 Asia Pacific Immunodiagnostics Market Revenue 2021-2030 (US$ Million)

6.3 Asia Pacific Immunodiagnostics Market Forecast Analysis

7. Asia Pacific Immunodiagnostics Market Analysis – by Product

7.1 Enzyme-Linked Immunosorbent Assays

7.1.1 Overview
7.1.2 Enzyme-Linked Immunosorbent Assays: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Chemiluminescence Immunoassays

7.2.1 Overview
7.2.2 Chemiluminescence Immunoassays: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Radioimmunoassays

7.3.1 Overview
7.3.2 Radioimmunoassays: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Immunodiagnostics Market Analysis – by Clinical Indication

8.1 Infectious Diseases

8.1.1 Overview
8.1.2 Infectious Diseases: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Hepatitis+HIV

8.2.1 Overview
8.2.2 Hepatitis+HIV: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Endocrinology

8.3.1 Overview
8.3.2 Endocrinology: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.4 Gastrointestinal

8.4.1 Overview
8.4.2 Gastrointestinal: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8.5 Metabolics

8.5.1 Overview
8.5.2 Metabolics: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Immunodiagnostics Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Metabolics: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Clinics

9.2.1 Overview
9.2.2 Metabolics: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Diagnostic Laboratories

9.3.1 Overview
9.3.2 Metabolics: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9.4 Academic & Research Institutes

9.4.1 Overview
9.4.2 Metabolics: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Immunodiagnostics Market – Asia-Pacific Analysis

10.1 Asia-Pacific

10.1.1 Asia Pacific Immunodiagnostics Market Breakdown, by Key Country, 2024 and 2030 (%)
10.1.1.1 Asia Pacific Immunodiagnostics Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 China: Asia Pacific Immunodiagnostics Market Breakdown, by Product
10.1.1.1.2 China: Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
10.1.1.1.3 China: Asia Pacific Immunodiagnostics Market Breakdown, by End User

10.1.1.2 India: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 India: Asia Pacific Immunodiagnostics Market Breakdown, by Product
10.1.1.2.2 India: Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
10.1.1.2.3 India: Asia Pacific Immunodiagnostics Market Breakdown, by End User

10.1.1.3 Japan: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Japan: Asia Pacific Immunodiagnostics Market Breakdown, by Product
10.1.1.3.2 Japan: Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
10.1.1.3.3 Japan: Asia Pacific Immunodiagnostics Market Breakdown, by End User

10.1.1.4 Australia: Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.4.1 Australia: Asia Pacific Immunodiagnostics Market Breakdown, by Product
10.1.1.4.2 Australia: Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
10.1.1.4.3 Australia: Asia Pacific Immunodiagnostics Market Breakdown, by End User

10.1.1.5 Rest of Asia-Pacific : Asia Pacific Immunodiagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Immunodiagnostics Market Breakdown, by Product
10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Immunodiagnostics Market Breakdown, by Clinical Indication
10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Immunodiagnostics Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Asia Pacific Immunodiagnostics Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 bioMerieux SA

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Danaher Corp

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 DiaSorin SpA

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 F. Hoffmann-La Roche Ltd

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 PerkinElmer Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Siemens Healthcare GmbH

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Svar Life Science AB

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Thermo Fisher Scientific Inc

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights